Evaluating the Investment Potential of RACL Geartech RACL Geartech would be one of the best investment decisions I have ever made, but one of my worst investment decisions too. I first purchased the stock at ₹67 per share in September 2018, which I consider one of my best investment decisions. But almost a year later, … Continue reading RACL Geartech’s Dream Run in the Stock Market
Category: Stock Analysis
Discuss the investment prospect of individual stocks based on the analysis and valuation of the stock’s fundamentals
A Quality Stock, But at a Premium Valuation
Control Print’s Recent Performance Analysis & Investment Stance Update Control Print has reported better earnings growth and profitability for the past two years. Its stock price performance over the past two years reflects this improved profitability. The stock has gained 17 percent in 2022 and 150 percent in 2023. We first discussed ‘Control Print’ in … Continue reading A Quality Stock, But at a Premium Valuation
Meghmani Organics: A Disappointing Year
Meghmani Organics' disappointing performance; challenges faced by the chemical industry; and positive initiatives for future growth. 8 Dec. 2023 Recap The stock performance of Meghmani Organics has been disappointing for investors in the past year. It experienced a loss of 32% in value, dropping from ₹111 to ₹75 per share. Over the last twelve months, … Continue reading Meghmani Organics: A Disappointing Year
CSB Bank Maintains its Competitive Position but Faces Impediments to Growth in the Near Term
The financial performance of CSB Bank for the quarter ended 30 Sep. 2023 has caught the attention of many investors and analysts. Despite a significant rise in Interest Income, the bank's net interest income has only slightly improved. The bank's cost-income ratio, which is the ratio of interest expense to interest income, has reached its … Continue reading CSB Bank Maintains its Competitive Position but Faces Impediments to Growth in the Near Term
The ESAF IPO is Attractively Priced
Despite the inherent riskiness of its business and high provisions, the stock has its merits. The Indian IPO market has seen increased activity over the last four months (July – October 2023). A total of twenty-eight IPOs, to be exact, occurred during the period: a lively market when compared to the nine IPOs that occurred … Continue reading The ESAF IPO is Attractively Priced
Analysis – Dynemic Products
24 Oct. 23 Dynemic Products Sector: Specialty Chemicals CMP: ₹303 per share Market Cap.: ₹354 crores The stock of Dynemic Products has been in a bear phase for the past two years. The stock declined from a high of ₹650 per share in November 2021 to ₹303 per share now. The period (last two years) … Continue reading Analysis – Dynemic Products
Analysis – Kovai Medical Center & Hospital
11 October 2023 Kovai Medical Center & Hospital Sector: Healthcare CMP: ₹2,590 per share Market Cap.: ₹2,832 crores Kovai Medical Center & Hospital (KMCH) is a Coimbatore-based multi-specialty hospital which, as per the company statement - “since starting operations with 200 beds in 1990, has grown into a 2,250 bed multi-locational, multi-disciplinary super specialty hospital, … Continue reading Analysis – Kovai Medical Center & Hospital
A Brief Intro. to the Stock Market
Do you invest in the Stock Market? If not… You should… Because… your wealth has a significant role in determining the quality of your life… and the Stock Market is the greatest wealth creator of our times. Here, I share briefly what I know on… how to go about investing in the stock market… and, … Continue reading A Brief Intro. to the Stock Market
Analysis – Natural Capsules
02-October-2023 Natural Capsules Sector: Pharmaceutical CMP: ₹383 per share Market Cap.: 353 crores Read PDF Natural Capsules began operations in 1993 by manufacturing hard capsules – which enclose the medicine to be delivered – for the pharmaceutical industry. Until FY20, the company had an unremarkable existence with stagnant sales and poor profitability. But during the … Continue reading Analysis – Natural Capsules
Significance of ‘Changes in Equity Statement’
The practice of publishing ‘Changes in Equity Statement’ by Indian Public Listed Companies along with the ‘Balance Sheet’, ‘Profit & Loss’, and ‘Cash flow’ statement is a recent development – FY2017-18 onwards, to be exact. The equity statement doesn’t receive the same level of attention the balance sheet, income, and cash flow statement receive during … Continue reading Significance of ‘Changes in Equity Statement’









